Table 2.
Dose (mg/m2) | Increase from prior dose level |
Number of patients treated |
---|---|---|
120 | – | 1 |
200 | 67% | 1 |
330 | 65% | 1 |
500 | 52% | 1 |
750 | 50% | 2a |
1050 | 40% | 1 |
1470 | 40% | 1 |
2060 | 40% | 6 |
One patient replaced due to disease progression on cycle 1 day 2 (new brain metastases)